Legal Representation
Attorney
Lawrence E. Abelman
USPTO Deadlines
Application History
28 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 18, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Sep 18, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Feb 18, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 16, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 16, 2017 | EXT2 | S | SOU EXTENSION 2 FILED |
| Feb 16, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 18, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 16, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 16, 2016 | EXT1 | S | SOU EXTENSION 1 FILED |
| Aug 16, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 16, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 22, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 22, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 2, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 18, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Nov 16, 2015 | ALIE | A | ASSIGNED TO LIE |
| Oct 2, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 29, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 29, 2015 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Sep 29, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 29, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 31, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 31, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 31, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 29, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 24, 2014 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Dec 23, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 22, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Injectable pharmaceutical preparations, namely, injectable dermal filler for moistening skin and reducing wrinkles; pharmaceutical preparations that prevent skin aging; pharmaceutical preparations for the treatment of glabellar lines and wrinkles on the face, asymmetries, defects and diseases of human skin; injectable dermal filler in gel form for filling of wrinkles for medical purposes; surgical implants comprising living tissues; gels for surgical and orthopedic purposes, namely, as a substitute surgical implant for joint fluid and soft body tissues; pharmaceutical products in gel form, namely, gel-like solutions for smoothing wrinkles and volumetric filling, for body contouring and for correction of soft body tissue defects, all for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the words "AQUA filling" in stylized letters in blue with a representation of a water drop in blue and white.
Color Claim
The color(s) blue and white is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"FILLING"